预计银屑病治疗市场在 2024 年至 2031 年期间的复合年增长率为 8.4%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
报告按药物类别(TNF抑制剂、PDE4 抑制剂、白细胞介素阻滞剂、其他)进行细分。报告进一步根据分子类型(生物制剂、小分子)进行分析。报告按给药途径(口服、肠胃外、局部)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。
报告目的
The Insight Partners 的《银屑病治疗市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
牛皮癣治疗市场细分
药物类别
- TNF抑制剂
- PDE4 抑制剂
- 白介素阻滞剂
- 其他的
分子类型
- 生物制剂
- 小分子
给药途径
- 口服
- 肠外
- 主题
地理
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
牛皮癣治疗市场的增长动力
- 银屑病患者数量不断增长:全球银屑病患者约占总人口的 2-3%,且数量还在不断增长,尤其是在北美和欧洲等国家,银屑病在这些国家造成数百万人痛苦。面对人口老龄化的不断增长,甚至有人估计银屑病的发病率将高于当前人口。随着患者群体的不断增长,对有效治疗的需求和相应的银屑病治疗市场也随之增长。人们对该疾病的认识不断提高,诊断方法也不断改进,这增加了确诊病例的负担,从而扩大了市场规模。
- 通过生物和靶向疗法获得最新突破:生物制剂的创新和新型靶向疗法确实重新定义了银屑病的治疗过程。生物制剂包括 TNF-alpha 抑制剂、IL-12/23 抑制剂和 IL-17 抑制剂,所有这些药物在治疗中度至重度银屑病方面都表现出极为有效的效果。这些新药物直接和共同作用于介导炎症过程的免疫系统途径,从此缓解症状,并与全身性类固醇相比将副作用降至最低。
- 认知和诊断不断提高:患者和医疗服务提供者对牛皮癣的认知改变了治疗该疾病的未来。教育和认知活动鼓励更多人提出问题并接受医生的诊断。早期识别可快速采取适当的有效治疗策略,从而提高患者的生活质量,并受益于分子诊断、基因型和生物标志物开发的进步。因此,更加个性化和准确的方法也推动了牛皮癣治疗方案的采用。
牛皮癣治疗市场未来趋势
- 个性化治疗方法:在这种转变的背景下,牛皮癣治疗的新兴市场将更加注重个性化医疗。患者的具体需求成为制定治疗计划的参数。个性化治疗计划所基于的参数包括疾病严重程度、遗传标记和对先前疗法的反应。基因组学和生物标记识别方面的新进展使医疗保健提供者能够为每位患者选择最合适的治疗方法,从而增加成功的机会。
- 口服疗法管道的需求出现:过去几年,生物制剂在银屑病治疗中占据主导地位,但口服疗法凭借与注射相比的便利性和简单性取得了进展。JAK 抑制剂、磷酸二酯酶抑制剂和其他新的小分子候选药物正在临床试验中进行探索。这些药物可能会为大部分患者提供更简单的治疗替代方案,使他们免于注射或去医院就诊,从而提高依从性。这些药物不会独立存在,而是会补充现有的治疗方法,并为未来治疗银屑病提供选择。
- 引入联合疗法:在治疗牛皮癣的联合疗法中,出现了新的治疗模式。生物制剂与传统外用药物或其他全身药物相结合,提供了新的治疗可能性,可以更好地控制疾病。这对于严重牛皮癣以及对之前的单一疗法没有反应的患者尤其重要。另一个重点领域是开发针对疾病机制不同途径的联合疗法。
牛皮癣治疗市场机会
- 创新生物制剂和生物仿制药的发展:随着许多畅销生物制剂的专利保护期即将到期,生物仿制药市场在银屑病治疗领域迎来了机遇之窗。生物仿制药使生物制剂价格实惠,从而让更多患者受益。这些产品进入成熟市场和新兴市场将为公司进入利润丰厚的银屑病治疗市场创造切入点,为消费者提供经济实惠的选择,而这些选择是品牌生物制剂无法提供的。
- 加大对早期干预的关注:随着医疗保健系统采用早期诊断和治疗慢性疾病,开发早期银屑病疗法的空间越来越大。早期干预疾病可防止病情恶化并改善长期健康结果。正在开发的支柱是针对轻度至中度银屑病的新型药物,可在疾病早期使用,因为制药公司认为这将形成一个全新的创新疗法市场。
- 与数字健康技术的融合:数字健康技术(如移动应用程序和远程医疗)的融合正在成为改善牛皮癣管理的巨大机遇。它们使人们能够查看和记录疾病的进展情况以及治疗的改善情况。移动应用程序越来越受欢迎,其功能是跟踪牛皮癣患者的皮肤状况、药物依从性和整体健康状况。通过投资建立的技术加上市场解决方案,很容易让公司在竞争中领先。
牛皮癣治疗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响银屑病治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的银屑病治疗市场细分和地理位置。

- 获取牛皮癣治疗市场的区域特定数据
牛皮癣治疗市场报告范围
报告属性 | 细节 |
---|---|
2024 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2025 - 2031) | 8.4% |
史料 | 2021-2023 |
预测期 | 2025-2031 |
涵盖的领域 | 按药物类别
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
银屑病治疗市场参与者密度:了解其对业务动态的影响
银屑病治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在牛皮癣治疗市场运营的主要公司有:
- 安斯泰来制药公司
- 阿斯利康公司
- 勃林格殷格翰公司
- F. 霍夫曼-拉罗什
- 葛兰素史克公司
免责声明:上面列出的公司没有按照任何特定顺序排列。

- 了解牛皮癣治疗市场的主要参与者概况
主要卖点
- 全面覆盖:该报告全面涵盖了牛皮癣治疗市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,《牛皮癣治疗市场》研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
The Psoriasis Therapeutics Market is estimated to witness a CAGR of 8.4% from 2023 to 2031
The major factors driving the Psoriasis Therapeutics market are:
1. Increasing Prevalence of Psoriasis
2. Advancements in Biologic and Targeted Therapies
Development of Novel Biologics and Biosimilars act as a opportunity for growth of the market in forecast period.
North America region dominated the Psoriasis Therapeutics market in 2023.
Biiologics segment, by molecule type, dominated the market in 2023.
Players operating in the market are Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Astellas Pharma Inc.
2. AstraZeneca plc,
3. Boehringer Ingelheim GmbH
4. F. Hofffmann-La Roche
5. GlaxoSmithKline plc
6. Merck & Co., Inc.
7. Valeant Pharmaceuticals International, Inc.
8. Biocon Limited
9. Eli Lilly and Company
10. G & W Laboratories Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.